Sarepta Therapeutics shares were higher after J.P. Morgan reduced its December 2025 price target to $84 from $169 and maintained its overweight rating. The stock was up 4% to $39.55 Tuesday and is ...

Investors at the Morningstar Investment Conference share which companies they are backing amid the wild market swings.

The president's press secretary said tax bill 'does not add to the deficit' President Donald Trump's press secretary, Karoline Leavitt, made a sweeping claim Monday, arguing that the president's tax ...

The Dow Jones Industrial Average (DJIA) hit a pause in its recent bullish momentum, sticking close to the 42,800 region on ...

S&P Global reports strong Q1 FY 2025 results, but DCF analysis suggests shares are overvalued. Click here to find out why ...

July NYMEX RBOB was 0.4ct lower at $2.0905/gal and June RBOB was nearly flat at $2.139/gal. July ULSD fell almost 1ct to $2.0815/gal and June ULSD was 1.25ct lower at $2.115/gal.

Bitcoin and crypto are becoming increasingly integrated into Wall Street and Washington. Pro-crypto policies are in favor, ...

The Dow Jones and the major indexes started the day lower Tuesday. Home Depot slipped on the stock market today after its ...

Moody’s Ratings became the last of the three major credit-rating agencies to say the U.S. federal government no longer deserves a top-tier AAA rating.

The S&P 500 is lagging an MSCI index tracking global stocks by more than 10 percentage points this year, according to Dow ...

U.S. markets edged lower in trading before the opening bell as the last few major companies report earnings amid a dearth of ...

Billionaire Ray Dalio weighed in on Moody’s recent downgrade of the U.S. creditworthiness, claiming the move understates the ...